APA (7th ed.) Citation

H, Y., M, Y., S, M., N, U., N, S., T, F., . . . S, Y. (2026). Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype. International journal of hematology, 123(5), 746. https://doi.org/10.1007/s12185-025-04155-1

Chicago Style (17th ed.) Citation

H, Yokoyama, et al. "Prognostic Factors Influencing Outcomes of Allogeneic HCT for AML with Monosomal Karyotype." International Journal of Hematology 123, no. 5 (2026): 746. https://doi.org/10.1007/s12185-025-04155-1.

MLA (9th ed.) Citation

H, Yokoyama, et al. "Prognostic Factors Influencing Outcomes of Allogeneic HCT for AML with Monosomal Karyotype." International Journal of Hematology, vol. 123, no. 5, 2026, p. 746, https://doi.org/10.1007/s12185-025-04155-1.